Background. Whether additional benefit can be achieved with the use of L-carnitine (L-C) in patients with chronic heart failure (CHF) remains controversial. We therefore performed a meta-analysis of randomized controlled trials (RCTs) to evaluate the effects of L-C treatment in CHF patients. Methods. Pubmed, Ovid Embase, Web of Science, and Cochrane Library databases, Chinese National Knowledge Infrastructure (CNKI) database, Wanfang database, Chinese Biomedical (CBM) database, and Chinese Science and Technology Periodicals database (VIP) until September 30, 2016, were identified. Studies that met the inclusion criteria were systematically evaluated by two reviewers independently. Results. 17 RCTs with 1625 CHF patients were included in this analysis. L-C treatment in CHF was associated with considerable improvement in overall efficacy (OR = 3.47, P < 0.01), left ventricular ejection fraction (LVEF) (WMD: 4.14%, P = 0.01), strike volume (SV) (WMD: 8.21 ml, P = 0.01), cardiac output (CO) (WMD: 0.88 L/min, P < 0.01), and E/A (WMD: 0.23, P < 0.01). Moreover, treatment with L-C also resulted in significant decrease in serum levels of BNP (WMD: −124.60 pg/ml, P = 0.01), serum levels of NT-proBNP (WMD: −510.36 pg/ml, P < 0.01), LVESD (WMD: −4.06 mm, P < 0.01), LVEDD (WMD: −4.79 mm, P < 0.01), and LVESV (WMD: −20.16 ml, 95% CI: −35.65 to −4.67, P < 0.01). However, there were no significant differences in all-cause mortality, 6-minute walk, and adverse events between L-C and control groups. Conclusions. L-C treatment is effective for CHF patients in improving clinical symptoms and cardiac functions, decreasing serum levels of BNP and NT-proBNP. And it has a good tolerance.

Abstract:We review recent progress in the development of high birefringence (Δn ≥ 0.12) negative dielectric anisotropy (Δε < 0) liquid crystals (LCs) for direct-view and projection displays. For mobile displays, our UCF-N2 (low viscosity, negative Δε, high Δn) based homogeneous alignment fringe-field switching (called n-FFS) mode exhibits superior performance to p-FFS in transmittance, single gamma curve, cell gap insensitivity, and negligible flexoelectric effect. For projection displays using a vertical alignment liquid-crystal-on-silicon (VA LCOS), our high birefringence UCF-N3 mixture enables a submillisecond gray-to-gray response time, which is essential for color sequential displays without noticeable color breakup. Our low viscosity UCF-N2 also enables multi-domain VA displays to use a thinner cell gap for achieving faster response time.

The use of fluorescence is ubiquitously found in the detection of immunoreaction; though with good sensitivity, this technique requires labeling as well as other time-consuming steps to perform the measurement. An alternative approach involving liquid crystals (LCs) was proposed, based on the fact that an immunocomplex can disturb the orientation of LCs, leading to an optical texture different from the case when only antigen or antibody exists. This method is label-free, easy to manipulate and low-cost. However, its sensitivity was low for practical usage. In this study, we adopted a high-birefringence liquid crystal (LC) to enhance the sensitivity for the immunodetection. Experiments were performed, targeting at the cancer biomarker CA125. We showed that the larger birefringence (Δn = 0.33 at 20 °C) amplifies the detected signal and, in turn, dramatically improves the detection limit. To avoid signal loss from conventional rinsing steps in immunodetection, CA125 antigen and antibody were reacted before immobilized on substrates. We studied the specific binding events and obtained a detection limit as low as 1 ng/ml. The valid temperature ranges were compared by using the typical single-compound LC 5CB and the high-birefringence LC mixture. We further investigated time dependency of the optical textures and affirmed the capability of LC-based immunodetection in distinguishing between specific and nonspecific antibodies.

A polymer-stabilized (PS) blue phase liquid crystal (BPLC) with fast response time and large Kerr constant is investigated by doping a low molecular weight monomer (N-vinylpyrrollidone) into a conventional PS-BPLC consisting of BPLC, RM257, and 1,1,1-trimethylolpropane triacrylate. With this polymer network system, Kerr constant and the response can be improved simultaneously. Compared to the conventional PS-BPLC, Kerr constant of the proposed PS-BPLC can increase by 54% and the response time can decrease by 23% at the same time. The contrast ratio can be kept at a high level, over 1000:1 at λ = 633 nm.